medline.ch Respirationstrakt Neoplasie

	Conversion Surgery After Induction Therapy for Initially Unresectable Stage III Non-small Cell Lung Cancer: A Proof-of-Concept Trial. Ann Surg Oncol Yan Y, Han Y, Niu Z, Zhang X, Li C, Cao Y, Yin Z, Zhu L, Hang J, Che J, Ren J, Xiang J, Chen K, Du H, Han D, Yang X, Zhang Y, Chen X, Jing H, Yu S, Wang X, Guo Z, Chen X, Luo F, Zhong W, Jin R, Li H. PMID: 41880079 [PubMed - as supplied by publisher]
	Diagnosis and management of esthesioneuroblastoma. Tunis Med El Omri M, Mosbah L, Naouar M, Bellakhdher M, Ghammem M, Houas J, Meherzi A, Kermani W, Mokni M, Abdelkefi M. PMID: 41879702 [PubMed - indexed for MEDLINE]
	A decade of Non-Small Cell Lung Cancer management: threats and opportunities in resource-limited setting. Tunis Med Mejri N, Haouari AA, Saadi M, Berrazaga Y, Haddeoui S, Ghorbel L, Boussen H, Rachdi H, Hamdi Y. PMID: 41879698 [PubMed - indexed for MEDLINE]
	Impact of Adverse Childhood Experience on Lung Cancer Risk: A Population-Based Prospective Cohort Study. Cancer Control Zhang Y, Li S, Shu C, Tao S, Shen G, Xie X, Xu C, Liu J, He Y, Liao H, Ma X. PMID: 41878887 [PubMed - indexed for MEDLINE]
	The Role of Advanced Lung Cancer Inflammation Index in Predicting COPD Exacerbation Risks. Int J Chron Obstruct Pulmon Dis Kwok WC, Leung SHI, Tam TCC, Chau CH, Lam FM, Ho JCM. PMID: 41878304 [PubMed - indexed for MEDLINE]
	The Role of PD-L1 in Lung Cancer: From Biology to Clinical Application. Immunotargets Ther Lamghari H, Karkouri M. PMID: 41878016 [PubMed]
	Emerging Predictive Biomarkers of Immunotherapy Sensitivity in Patients with Non-Small Cell Lung Cancer. Immunotargets Ther Gariazzo E, Colamartini F, Ubaldi M, Santo V, Brunetti L, Tomarelli C, Ognissanti D, Nassar J, Costabile S, Romano L, De Vita E, Scorpiniti I, Macrì M, Porreca R, Currà MF, Cortellini A, Ricciuti B, Metro G. PMID: 41878015 [PubMed]
	Sarcopenia Predicts Outcome After Chemoimmunotherapy, Not Chemotherapy, in Advanced Lung Cancer: Single-Centre Retrospective Study. J Cachexia Sarcopenia Muscle Lee H, Kim CG, Han S, Park SK, Yoon HI, Kim KH, Shim HS, Hong MH, Yeo JH, Kim S, Hwang SH, Kim HR, Hong N. PMID: 41877592 [PubMed - indexed for MEDLINE]
	Safety and efficacy of intrathecal pemetrexed and bevacizumab in non-small cell lung cancer (NSCLC) patients with leptomeningeal metastases (LM): protocol for a single-arm, prospective, phase Ia trial. BMJ Open Kuang Y, Teng J, Wang W, Zhang B, Cheng L, Zhang Y, Liu W, Gao Z, Nie W, Xiong L, Shi C, Zhang W, Lou Y, Han B, Zhong H. PMID: 41877338 [PubMed - indexed for MEDLINE]
	Effect of home-based walking exercise and education on early functional recovery after lung cancer surgery: protocol for the WalkLung multicentre randomised controlled trial. BMJ Open Zhang Y, Liu X, Shi X, Feng P, Chen Y, Lei C, Zeng H, Li T, Gui P, Li M, Wang L, Zhang R, He Y, Chen Y, Chen D, Zhang Y, Liao J, Wei X, Tian B, Liu X, Li Q, Shi Q, Chen X, Dai W. PMID: 41877328 [PubMed - indexed for MEDLINE]
	Cellular landscape and diagnostic value of TROP2 in cerebrospinal fluid of lung adenocarcinoma leptomeningeal metastases. NPJ Precis Oncol Wang Z, Luo J, Jin Y, Wang T, Mu Y, Liu J, Ju H, Wu Y, Ou Q, Guan M, Ruan H. PMID: 41876785 [PubMed - as supplied by publisher]
	AI-based chest X-ray prioritization in the lung cancer diagnostic pathway: the LungIMPACT randomized controlled trial. Nat Med Woznitza N, Smith L, Rawlinson J, Au-Yong I, George B, Djearaman MG, Nair A, Lee RW, Navani N, Ndwandwe S, Clarke CS, Creeden A, Newsome J, Das I, Abaokporo S, Tucker R, Hathorn J, Baldwin DR. PMID: 41876649 [PubMed - as supplied by publisher]
	Remodeling the fortress: phytochemical-loaded nanocarriers to disrupt the therapy-resistant lung tumor microenvironment. Int J Pharm Bushra B, Khand FM, Lakho SA, Zahid A, Ali S, Li G. PMID: 41875956 [PubMed - as supplied by publisher]
	Letters to the Editorconcern regarding the accuracy of ESMO guidelines citation on adjuvant platinum-based chemotherapy timing in non-small cell lung cancer. Cancer Treat Res Commun Zhu X. PMID: 41875829 [PubMed - as supplied by publisher]
	A subgroup analysis of perioperative pembrolizumab in clinical stage II non-small-cell lung cancer from the randomized keynote-671 study. Eur J Cardiothorac Surg Tsuboi M, Wakelee H, Garassino MC, Gao S, Luft A, Chen KN, Spicer JD, Zhu Y, Saji H, Okada M, Vanakesa T, Chen H, Zhao G, Ikeda N, Jones DR, Weksler B, Huang CS, Jensen E, Keller SM, Samkari A, Liberman M. PMID: 41875364 [PubMed - as supplied by publisher]
	The Current Landscape of Remote Digital Symptom Monitoring for Patients With Lung Cancer: Scoping Review. J Med Internet Res Huang H, Takemura N, Abu-Odah H, Li S, Mao T, Ye Z, Yorke J. PMID: 41875242 [PubMed - indexed for MEDLINE]
	HCLmNet: A unified hybrid continual learning strategy multimodal network for lung cancer survival prediction. PLoS One Bappi MI, Richter DJ, Kolekar SS, Kim K. PMID: 41875207 [PubMed - indexed for MEDLINE]
	Integrated Implementation Strategies to Promote the Use of AI-Assisted Diagnostic Software for Lung Nodule Screening in China: Process Evaluation Based on the RE-AIM Framework. JMIR Form Res Liao X, Tian Y, Cheng Y, Sun X, Zhang Y, Tang Y, Zhao Z, Lun Y, Wang S, Li Y, Fu Y, Zong D, Chen L, Wang Q, Zhang H, Yao C, Chen D. PMID: 41875027 [PubMed - indexed for MEDLINE]
	Analysis of pleural fluid biomarkers for diagnosis of malignant pleural effusion and molecular characterization of lung cancer: a review. Curr Opin Pulm Med Schwalk AJ, Abu-Rmaileh M, Grosu HB. PMID: 41873502 [PubMed - as supplied by publisher]
	A practical framework for physicians and researchers to assess diagnostic bronchoscopy technologies in lung cancer. Curr Opin Pulm Med Ost DE. PMID: 41873499 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 158305

Seite 1 von 7916



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung